Metraipolis › archive › dc_185d050a5fa4

Genomic and Epigenomic Advances in Hearing Loss: Molecular Mechanisms, Diagnostics, and Emerging Therapies — Europe PMC PMID:42346617

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346617
DOI
10.3390/jpm16060306
License (as archived)
solo-consultazione
Archived
2026-10-08T01:12:33.781Z
SHA-256 of the archived text
8ea1070dbffe5fadb5d78bfaa9b8dc7b94f962f48506f81d53a385a982d4b046
Stable URL of this page
https://metraipolis.com/documento/dc_185d050a5fa4

How to cite

Genomic and Epigenomic Advances in Hearing Loss: Molecular Mechanisms, Diagnostics, and Emerging Therapies — Europe PMC PMID:42346617 — Europe PMC (en), https://europepmc.org/article/MED/42346617 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_185d050a5fa4 (Metraipolis archive dc_185d050a5fa4, sha256 8ea1070dbffe5fadb5d78bfaa9b8dc7b94f962f48506f81d53a385a982d4b046)
BibTeX
@misc{dc185d050a5fa4,
  title = {Genomic and Epigenomic Advances in Hearing Loss: Molecular Mechanisms, Diagnostics, and Emerging Therapies — Europe PMC PMID:42346617},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346617},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_185d050a5fa4; sha256 8ea1070dbffe5fadb5d78bfaa9b8dc7b94f962f48506f81d53a385a982d4b046},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346617. Agents can read the archived copy with the MCP tool read_document.